Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142520

Published: 2020

Journal Articles

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Fernanda de Morais Marques, Verena Pfister, Flavia Parra, Mihoko Yamamoto, MD PhD, Rodrigo Santucci Silva, MD, Marcelo Bellesso, MD, Vinicius Campos de Molla, MD, Ana Rita Da Fonseca, MD, Yana Novis, MD, Sérgio Costa Fortier, MD, Talita Silveira, MD PhD, Guilherme Brasil Duffles Amarante, MD, Valeria Buccheri, Matheus Vescovi, MD PhD, Carlos Sérgio Chiattone, MD PhD, Celso Arrais, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142810

Published: 2020

Journal Articles

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Vinicius Campos de Molla, MD, Matheus Vescovi Gonçalves, MD PhD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 5666.

https://doi.org/10.1182/blood-2019-126221

Published: 2019

Journal Articles

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Dante Escorcio-Tavares, Vinicius Campos de Molla, MD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD, Matheus Vescovi Gonçalves, MD PhD

Blood (2019) 134 (Supplement_1): 3295.

https://doi.org/10.1182/blood-2019-128263

Published: 2019

Journal Articles

Metabolomic Profile in Patients with Autoimmune Hemolytic Anemia

Iara Baldim Rabelo, MD PhD, Akemi Kuroda Chiba, Pharmacist, MS, Elyse Moritz, Pharmacist, PhD, Melca Oliveira Barros, MD PhD, Ismael Dale Cotrim Guerreiro Silva, MD PhD, Jose Orlando Bordin, MD PhD, Maria de Lourdes Chauffaille, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2018) 132 (Supplement 1): 3622.

https://doi.org/10.1182/blood-2018-99-116275

Published: 2018

Journal Articles

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Nayara Ribeiro Guedes, Juliana Goncalves, MD, Marcelo Lacerda, MD, Maria Cristina Nunez, ANA RITA F B Medeiros, MD, Ana Carolina Kirchmeyer, Andre domingues Pereira, MD, Patricia Eiko Yamakawa, MD, Melca Oliveira Barros, MD PhD, Matheus Vescovi, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2017) 130 (Supplement 1): 4961.

https://doi.org/10.1182/blood.V130.Suppl_1.4961.4961

Published: 2017

Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 4434.

https://doi.org/10.1182/blood.V128.22.4434.4434

Published: 2016

Journal Articles

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

Mariana Bleker de Oliveira, BSc, Angela Isabel Eugenio, BSc, Veruska Lia Fook Alves, PhD, Daniela Zanatta, PhD, Mihoko Yamamoto, MD PhD, Bryan Eric Strauss, PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5658.

https://doi.org/10.1182/blood.V128.22.5658.5658

Published: 2016

Journal Articles

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Mariana Bleker de Oliveira, BSc, Veruska Lia Fook Alves, PhD, Angela Isabel Eugenio, BSc, Rodrigo Carlini Fernando, BSc, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5663.

https://doi.org/10.1182/blood.V128.22.5663.5663

Published: 2016

Journal Articles

Hydroxycarbamide Is Related with Higher Expression of Band-3 and CD59 in Sickle Erythrocytes

Grazielle Mecabo, postgraduate student, Mihoko Yamamoto, MD PhD, Eliza Y. S. Kimura, Fabio P. Guirao, Maria Stella Figueiredo, MD PhD

Blood (2014) 124 (21): 4913.

https://doi.org/10.1182/blood.V124.21.4913.4913

Published: 2014

Journal Articles

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Thiago Xavier Carneiro, MD, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4625.

https://doi.org/10.1182/blood.V122.21.4625.4625

Published: 2013

Journal Articles

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Ana Paula Vaz Carvalho, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4626.

https://doi.org/10.1182/blood.V122.21.4626.4626

Published: 2013

Journal Articles

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Matheus Vescovi GonÇalves, MD, Mihoko Yamamoto, MD, PhD, Vergílio Antônio Rensi Colturato, MD, Mair Pedro de Souza, Marcos Mauad, MD, Maura Valerio Ikoma, MD, PhD, Eliza Y. S. Kimura, Fabio P. Guirao, Nelson Hamerschlak, MD, Fabio R. Kerbauy, MD, Leonardo Raul Morelli, Yana Novis, MD, valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2011) 118 (21): 4541.

https://doi.org/10.1182/blood.V118.21.4541.4541

Published: 2011

Journal Articles

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Luis Arthur F. Pelloso, MD, PhD, Sandra Serson Rohr, MD, Mihoko Yamamoto, MD, PhD, Maria de Lourdes L. F. Chauffaille, MD, PhD

Blood (2011) 118 (21): 4262.

https://doi.org/10.1182/blood.V118.21.4262.4262

Published: 2011

Journal Articles

Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia

Gustavo Loureiro, MD, Daniella Bahia Kerbauy, MD, PhD, Maria de Lourdes, MD, PhD, L. F. Chauffaille, Maria Lucia M. Lee, MD, Franciele B. M. Candido, MD, Marçal C.A Silva, MD, Eliza Y. S. Kimura, Fabio P. Guirao, Denise C. Rezende, Mihoko Yamamoto, MD, PhD

Blood (2010) 116 (21): 3240.

https://doi.org/10.1182/blood.V116.21.3240.3240

Published: 2010

Journal Articles

PI3K/AKT Pathway as a Potential Therapeutic Target In Myelodysplastic Syndrome

Denise C Rezende, PhD, Lorena Zaida Pacheco, master, Luis Arthur F. Pelloso, MD, PhD, Maria L. Chauffaille, MD, PhD, Marçal C.A Silva, MD, Elisa Kimura, Rafael L Casaes-Rodrigues, master, Helena Segreto, MD, PhD, Mihoko Yamamoto, MD, PhD, Daniella Marcia Maranhao Bahia Kerbauy, MD, PhD

Blood (2010) 116 (21): 1871.

https://doi.org/10.1182/blood.V116.21.1871.1871

Published: 2010

Journal Articles

Novel Kel null Allele Detected In a Brazilian Woman with the Kell Null Phenotype.

Edmir Boturão-Neto, MD, PhD, Mihoko Yamamoto, MD, PhD, Akemi Kuroda Chiba, MSc, Elisa Yuriko Sugano Kimura, Maria do Carmo V. C. Oliveira, MSc, José Orlando Bordin, MD, PhD

Blood (2010) 116 (21): 1111.

https://doi.org/10.1182/blood.V116.21.1111.1111

Published: 2010

Journal Articles

A134T, G156A and G1333A SNPs in the CD177 Gene Are Associated with Atypical Expression of Human Neutrophil Antigen 2a (HNA-2a)

Elyse Moritz, Akemi Kuroda Chiba, Msc, Dulcinéia M Albuquerque, Msc, Fernando F Costa, MD, PhD, Mihoko Yamamoto, MD, PhD, Jose Orlando Bordin, MD, PhD

Blood (2008) 112 (11): 4646.

https://doi.org/10.1182/blood.V112.11.4646.4646

Published: 2008

Journal Articles

VEGF Expression as Prognostic Factor in Early Clinical Stages of Chronic Lymphocytic Leukemia Patients

Wolney Góis Barreto, MD, Grazziella Curado Siufi, MD, Eliza YS Kimura, BSC, Juliana Gilbert Pessoa, MD, Joao Bosco Pesqueiro, MD., PHD., Yuri Vasconcelos, MD, PhD, Marcal CA Silva, MD, Arlete E Lazar, Mihoko Yamamoto, MD, PhD

Blood (2008) 112 (11): 4173.

https://doi.org/10.1182/blood.V112.11.4173.4173

Published: 2008

Journal Articles

LPL and ADAM-29 Gene Expressions Stratify Prognosis in Clinical Stage BinetA and B Chronic Lymphocytic Leukemia Patients

Wolney Góis Barreto, MD, Lorenza Oliveira Belluzzi, Grazziella Curado Siufi, MD, Marçal Cavalcante de Andrade Silva, MD, Eliza Yuriko Sugano Kimura, BSc, Yuri Vasconcelos, MD, PhD, Inara Lucia Arce, MD, Mihoko Yamamoto, MD, PhD

Blood (2008) 112 (11): 4177.

https://doi.org/10.1182/blood.V112.11.4177.4177

Published: 2008

NARROW

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Metabolomic Profile in Patients with Autoimmune Hemolytic Anemia

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Hydroxycarbamide Is Related with Higher Expression of Band-3 and CD59 in Sickle Erythrocytes

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia

PI3K/AKT Pathway as a Potential Therapeutic Target In Myelodysplastic Syndrome

Novel Kel null Allele Detected In a Brazilian Woman with the Kell Null Phenotype.

A134T, G156A and G1333A SNPs in the CD177 Gene Are Associated with Atypical Expression of Human Neutrophil Antigen 2a (HNA-2a)

VEGF Expression as Prognostic Factor in Early Clinical Stages of Chronic Lymphocytic Leukemia Patients

LPL and ADAM-29 Gene Expressions Stratify Prognosis in Clinical Stage BinetA and B Chronic Lymphocytic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only